Here’s whether Pfizer Inc. (PFE) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+0.83% over 10 days); RSI 55 — healthy momentum range; strong 1-year return of +25.1%; 3-month momentum positive (+7.5%). Currently 4.1% off its 52-week high. Score: +7/7.
PFE is in a confirmed uptrend, trading above both its 50-day ($27.23) and 200-day ($25.61) moving averages. An RSI of 55.2 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +25.1% compares to +35.1% for SPY (trailed the market by 10.0%).
$10,000 invested 1 year ago→ $12,505 today
vs. S&P 500 (SPY) — same period trailed market by 10.0%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($25.61)
✓Above 50-day MA ($27.23)
✓RSI(14) neutral zone (30–70) — currently 55.2
✓Positive return (+25.1%)
✓Within 10% of period high (−4.1%)
Period Range $27.56
$21.87$28.75
RSI (14) 55.2
0 · OversoldOverbought · 100
Key Metrics
Price$27.56
Period Return+25.1%
Period High$28.75
Period Low$21.87
Drawdown−4.1%
MA-50$27.23
MA-200$25.61
RSI (14)55.2
Avg Volume (30d)38.5M
vs. SPYtrailed by 10.0%
Return Rank#529 of 996
Trend Signals
Price is above the 200-day moving average ($25.61)